Team Eric Ginsburg, PhD Senior Director, Intellectual Property and Technology Development Senior Director, Intellectual Property and Technology Development
Page Where Are They Now? Episode 3 Episode 3: BenchPrep April 29, 2021 Ashish Rangnekar, MBA ’11, grew up in a sleepy town in India where success looked like a white-collar job, not entrepreneurship. But early on...
Technology A Chimeric Antigen Coreceptor System For Optimized Antigen Targeting A novel chimeric antigen coreceptor system mimicking the CD4/CD8 and TCR interaction to enhance signaling for increased antigen sensitivity to treat B cell malignancies. The unmet need: Solutions for…
News Eric Lefkofsky’s Tempus Will Use Data to Help UChicago Battle Breast Cancer Tempus, the cancer fighting startup from Groupon founder Eric Lefkofsky, wants to give doctors at the University of Chicago data to help better treat breast cancer patients. Read more.
Technology Potentiating the Microbiome for the Prevention of Enteric Bacterial Infection in Livestock Approximately 1/5 of antibiotic resistant infections in humans can be traced back to food and animals. The incidence of these infections is perpetuated by the widespread prophylactic use of antibiotics…
News Polsky Center Names 13 Companies Participating in the 2019 Summer Accelerator Program The latest cohort of the Polsky Accelerator, a 10-week intensive summer program designed for both for-profit and not-for-profit startups, is announced.
News Digital Adventures Wins ‘Crowd Favorite’ at the 2019 Polsky Accelerator Demo Day For the past 10 weeks, 13 companies have participated in the 2019 Polsky Accelerator program. The annual program is designed for both for-profit and not-for-profit startups to develop their ventures....
News Eric Isaacs named as 2017 National Academy of Inventors Fellow Eric D. Isaacs, executive vice president for research, innovation and national laboratories at the University of Chicago has been named as a 2017 fellow of the National Academy of Inventors...
Technology Type I Interferons For Enhancing Chimeric Antigen Receptor T-Cell Efficacy Method to enhance CAR T-cell efficacy by incorporating low-dose exogenous IFN-α2 into CD19-directed, CD28-costimulated CAR T cells post-transduction during manufacturing boosting cytolytic molecule expression, cytokine secretion, and cytotoxicity while minimizing…
News Alumni New Venture Challenge Selects 25 Startups for 2022 Contest The Polsky Center for Entrepreneurship and Innovation is pleased to announce the 25 startups accepted into the 2022 Alumni New Venture Challenge (ANVC), a global competition dedicated to supporting all University of...
News 22 Teams From Across Campus Explore Commercial Potential of New Ideas More than 20 teams participated in the Polsky Center I-Corps program this academic year – all with new research and ideas addressing challenges across various industries. The goal of the...
